CoChat

Amyloid, Presenilins, and Alzheimer’s Disease

Gassen, Geert Van, Annaert, Wim · 2003 · The Neuroscientist
Cited by 41

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

The regulated intramembrane proteolysis of the amyloid precursor protein (APP) that results in the generation of a toxic 40 to 42 amino acid fragment, Aβ, and a C-terminal intracellular fragment stands central in the pathogenesis of Alzheimer’s disease. The fibrillar Aβ peptide is extracellularly deposited in plaques in the amygdala, the hippocampus, and the neocortex of affected individuals. The APP intracellular fragment binds to transcription factors and is translocated to the nucleus, where it influences transcription. Regulated intramembrane proteolysis of APP is dependent on the activity of a multimeric protein complex of which the essential components are presenilin, nicastrin, PEN-2, and APH-1. Further research into this emerging field of presenilin-dependent APP proteolysis within the plane of the membrane might reveal the necessity of an additional transport step—bringing substrate and enzyme together—before APP can actually be processed. NEUROSCIENTIST 9(2): 117–126, 2003.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/1073858403252227

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 41

Metadata

Authors
Gassen, G. V., & Annaert, W.
Venue
The Neuroscientist
Published
2003-04
Volume
9
Issue
2
Pages
117-126
ISSN
  • 1073-8584 (ISSN-L)
  • 1089-4098
OpenAlex
W1966880627
Cited by
41
References
18
FWCI
3.44
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amyloid, Presenilins, and Alzheimer’s Disease. https://app.cochat.ai/papers/10.1177/1073858403252227
The paper
Gassen, G. V., & Annaert, W. (2003). Amyloid, Presenilins, and Alzheimer’s Disease. The Neuroscientist. https://doi.org/10.1177/1073858403252227

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.